Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug‐Resistant HIV‐1 Infection
Open Access
- 15 July 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (2) , 236-242
Abstract
Background. Maximum suppression of virus replication is often not achievable for persons infected with multidrug-resistant human immunodeficiency virKeywords
This publication has 20 references indexed in Scilit:
- Lamivudine Can Exert a Modest Antiviral Effect against Human Immunodeficiency Virus Type 1 Containing the M184V MutationAntimicrobial Agents and Chemotherapy, 2003
- Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and IndinavirAntimicrobial Agents and Chemotherapy, 2001
- Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotypeAIDS, 1999
- Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level withRisk of Clinical Progression in Patients with Advanced InfectionThe Journal of Infectious Diseases, 1996
- Phase 1 Study of Combination Therapy with L-697,661 and ZidovudineJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Variation in Plasma RNA Levels, CD4 Cell Counts, and p24 Antigen Levels in Clinically Stable Men with Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1996
- Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In VitroThe Journal of Infectious Diseases, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)The Journal of Infectious Diseases, 1995
- Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 RnaThe Journal of Infectious Diseases, 1994